secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-05-29T21:07:05+00:00
Accession:  0001021771-26-000084
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements
--------------------------------------------------------------------------------

- CEO Lance Alstodt signed 3-year employment agreement with $600k annual salary, unchanged.
- CFO Robert Kristal signed 3-year employment agreement with $350k annual salary, unchanged.
- Shareholders approved increase in authorized common shares from 75M to 1.5B (20x).
- Vote: 9,868,606 for, 2,389,059 against, 179,207 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/0001021771-26-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/brtx-20260529.htm
  HTML page:      https://secwatch.observer/filing/0001021771-26-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer